Successful Treatment of Recurrent Epithelioid Sarcoma-like Hemangioendothelioma with Mohs Micrographic Surgery

Main Article Content

David Dayi Xiong
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Christina Wong
Department of Dermatology, Cleveland Clinic Foundation

Keywords

Epithelioid sarcoma-like hemangioendothelioma, pseudomyogenic hemangioendothelioma, Mohs micrographic surgery, Mohs, Cutaneous oncology, Vascular tumor, Oncology

Abstract

Abstract not available.

References

1. Billings S, Folpe A, Weiss S. Epithelioid Sarcoma-Like Hemangioendothelioma. The American Journal of Surgical Pathology. 2003;27(1):48-57.

2. Hornick J, Fletcher C. Pseudomyogenic Hemangioendothelioma. The American Journal of Surgical Pathology. 2011;35(2):190-201. doi:10.1097/PAS.0b013e3181ff0901

3. Al-Qaderi A, Mansour AT. Pseudomyogenic Hemangioendothelioma. Archives of Pathology & Laboratory Medicine. 2018;143(6):763-767. doi:10.5858/arpa.2017-0430-RS

4. Caballero GA, Roitman PD. Pseudomyogenic Hemangioendothelioma (Epithelioid Sarcoma-Like Hemangioendothelioma). Archives of Pathology & Laboratory Medicine. April 2019. doi:10.5858/arpa.2018-0395-RS

5. Gabor KM, Sapi Z, Tiszlavicz LG, Fige A, Bereczki C, Bartyik K. Sirolimus therapy in the treatment of pseudomyogenic hemangioendothelioma. Pediatric Blood & Cancer. 2018;65(2):e26781. doi:10.1002/pbc.26781

6. Ozeki M, Nozawa A, Kanda K, et al. Everolimus for Treatment of Pseudomyogenic Hemangioendothelioma. J Pediatr Hematol Oncol. 2017;39(6):e328-e331. doi:10.1097/MPH.0000000000000778

Article Sidebar

PDF
Published
Jul 12, 2020
DOI https://doi.org/10.25251/skin.4.4.21

Article Details

How to Cite
Xiong, D. D., & Wong, C. (2020). Successful Treatment of Recurrent Epithelioid Sarcoma-like Hemangioendothelioma with Mohs Micrographic Surgery. SKIN The Journal of Cutaneous Medicine, 4(4), 383–385. https://doi.org/10.25251/skin.4.4.21
Issue
Vol. 4 No. 4 (2020)
Section
Short Communications
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)